- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Mycophenolic acid (CAT#: Vinh-005SX)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-005SX |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexanoic acid; NSC129185, Immunomodulator
- Target
- SARS-CoV-2
- Molecular Formula
- C17H20O6
- Molecular Weight
- 320.3 g/mol
- Purity
- >98% by HPLC
- Storage
- Store at -20°C.
- Introduction
- Mycophenolic acid (MPA), an immunosuppressant, is an uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). The immunomodulator has been actively studied for its in vitro antiviral potency against a broad family of viruses including seasonal influenza and MERS and has shown a positive effect on improving the state of patients suffering from severe pneumonia caused by these viruses. As a potent IMPDH inhibitor, scientists are studying its antiviral role against the SARS-COV-2 virus, as studies suggest that the novel virus interacts with cellular IMPDH2 utilizing the Nsp14 viral protein.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.